| [1] |
Moman RN, Gupta N, Varacallo M. Physiology, albumin[M]. StatPearls. Treasure Island (FL): StatPearls Publishing, 2022.
|
| [2] |
Ishima Y, Maruyama T. Human serum albumin as carrier in drug delivery systems[J]. Yakugaku Zasshi, 2016, 136(1): 39-47.
|
| [3] |
Garcia-Martinez R, Caraceni P, Bernardi M, et al. Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications[J]. Hepatology, 2013, 58(5): 1836-1846.
|
| [4] |
Domenicali M, Baldassarre M, Giannone FA, et al. Posttranscriptional changes of serum albumin: clinical and prognostic significance in hospitalized patients with cirrhosis[J]. Hepatology, 2014, 60(6): 1851-1860.
|
| [5] |
Caraceni P, Tufoni M, Zaccherini G, et al. On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites[J]. J Hepatol, 2021, 74(2): 340-349.
|
| [6] |
Ge P, Liao W, Yang H, et al. Reduction in albumin binding function following liver resection in patients with and without cirrhosis[J]. Transl Cancer Res, 2016, 5(6): 756-764.
|
| [7] |
Fernández J, Clària J, Amorós A, et al. Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis[J]. Gastroenterology, 2019, 157(1): 149-162.
|
| [8] |
Jeong HW, Kim JW, Shin WJ, et al. Early postoperative hypoalbuminaemia is associated with pleural effusion after donor hepatectomy: A propensity score analysis of 2 316 donors[J]. Sci Rep, 2019, 9(1): 2790.
|
| [9] |
Lee CW, Tsai HI, Sung CM, et al. Risk factors for early mortality after hepatectomy for hepatocellular carcinoma[J]. Medicine (Baltimore), 2016, 95(39): e5028.
|
| [10] |
黄东海, 施建设, 张诚华. 原发性肝癌合并肝硬化患者肝切除术后人血白蛋白的应用分析[J]. 临床肝胆病杂志, 2015, 31(6): 910-914.
|
| [11] |
Li H, Wu JS, Wang XT, et al. Factors predicting surgical resection in patients with intrahepatic cholangiocarcinoma and cirrhosis[J]. J Invest Surg, 2014, 27(4): 219-225.
|
| [12] |
Poon RT, Fan ST, Lo CM, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1 222 consecutive patients from a prospective database[J]. Ann Surg, 2004, 240(4): 698-708.
|
| [13] |
Carvalho JR, Verdelho Machado M. New insights about albumin and liver disease[J]. Ann Hepatol, 2018, 17(4): 547-560.
|
| [14] |
Bernardi M, Angeli P, Claria J, et al. Albumin in decompensated cirrhosis: new concepts and perspectives[J]. Gut, 2020, 69(6): 1127-1138.
|
| [15] |
Demirtas CO, D’Alessio A, Rimassa L, et al. ALBI grade: evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma[J]. JHEP Rep, 2021, 3(5): 100347.
|
| [16] |
Wang YY, Zhong JH, Su ZY, et al. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma[J]. Br J Surg, 2016, 103(6): 725-734.
|
| [17] |
Kokudo T, Hasegawa K, Amikura K, et al. Assessment of preoperative liver function in patients with hepatocellular carcinoma - the albumin-indocyanine green evaluation (ALICE) grade[J]. PLoS One, 2016, 11(7): e0159530.
|
| [18] |
Zhang L, Chen QG, Li SQ, et al. Preoperative fibrinogen to prealbumin ratio as a novel predictor for clinical outcome of hepatocellular carcinoma[J]. Future Oncol, 2019, 15(1): 13-22.
|
| [19] |
中国研究型医院学会微创外科学专业委员会, 《腹腔镜外科杂志》编辑部. 吲哚菁绿荧光染色在腹腔镜肝切除术中应用的专家共识[J]. 腹腔镜外科杂志, 2019, 24(5): 388-394.
|
| [20] |
张皓萌. 白蛋白-吲哚菁绿评分（ALICE）系统在门静脉高压合并肝癌肝切除的应用价值[D]. 沈阳: 中国医科大学, 2020.
|
| [21] |
Kudo M, Kawamura Y, Hasegawa K, et al. Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 update[J]. Liver Cancer, 2021, 10(3): 181-223.
|
| [22] |
Botwin GJ, Morgan TR. Bacterial infections in cirrhosis[J]. Hepatol Int, 2014, 8 Suppl 2: 467-474.
|
| [23] |
Cavallin M, Piano S, Romano A, et al. Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study[J]. Hepatology, 2016, 63(3): 983-992.
|
| [24] |
Pessaux P, Msika S, Atalla D, et al. Risk factors for postoperative infectious complications in noncolorectal abdominal surgery: A multivariate analysis based on a prospective multicenter study of 4 718 patients[J]. Arch Surg, 2003, 138(3): 314-324.
|
| [25] |
Elloumi H, Sabbah M, Bibani N, et al. Effect of low dose albumin administration in spontaneous bacterial peritonitis on renal function and survival[J]. Arab J Gastroenterol, 2019, 20(4): 205-208.
|
| [26] |
Sobhonslidsuk A. Current position of vasoconstrictor and albumin infusion for type 1 hepatorenal syndrome[J]. World J Gastrointest Pharmacol Ther, 2015, 6(3): 28-31.
|
| [27] |
Caraceni P, Riggio O, Angeli P, et al. Long-term albumin administration in decompensated cirrhosis (ANSWER): An open-label randomised trial[J]. Lancet, 2018, 391(10138): 2417-2429.
|
| [28] |
Philips CA, Maiwall R, Sharma MK, et al. Comparison of 5% human albumin and normal saline for fluid resuscitation in sepsis induced hypotension among patients with cirrhosis (FRISC study): A randomized controlled trial[J]. Hepatol Int, 2021, 15(4): 983-994.
|
| [29] |
Kamiyama T, Nakanishi K, Yokoo H, et al. Perioperative management of hepatic resection toward zero mortality and morbidity: analysis of 793 consecutive cases in a single institution[J]. J Am Coll Surg, 2010, 211(4): 443-449.
|
| [30] |
Chancharoenthana W, Leelahavanichkul A. Acute kidney injury spectrum in patients with chronic liver disease: where do we stand?[J]. World J Gastroenterol, 2019, 25(28): 3684-3703.
|
| [31] |
李慧博, 门鹏, 王宇, 等. 《人血白蛋白用于肝硬化治疗的快速建议指南》解读[J]. 临床药物治疗杂志, 2018, 16(12): 10-16.
|
| [32] |
李慧博, 门鹏, 徐小元, 等. 人血白蛋白用于肝硬化治疗的快速建议指南计划书[J]. 药物流行病学杂志, 2017, 26(11): 781-785.
|
| [33] |
European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis[J]. J Hepatol, 2010, 53(3): 397-417.
|
| [34] |
Runyon BA, AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: An update[J]. Hepatology, 2009, 49(6): 2087-2107.
|
| [35] |
Runyon BA, Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Management of adult patients with ascites due to cirrhosis[J]. Hepatology, 2004, 39(3): 841-856.
|
| [36] |
Abbas N, Makker J, Abbas H, et al. Perioperative care of patients with liver cirrhosis: A review[J]. Health Serv Insights, 2017, 10: 1178632917691270.
|
| [37] |
中华医学会外科学分会肝脏外科学组. 肝切除术围手术期管理专家共识[J]. 中国实用外科杂志, 2017, 37(5): 525-530.
|
| [38] |
Yu YT, Liu J, Hu B, et al. Expert consensus on the use of human serum albumin in critically ill patients[J]. Chin Med J (Engl), 2021, 134(14): 1639-1654.
|
| [39] |
Piano S, Tonon M, Angeli P. Management of ascites and hepatorenal syndrome[J]. Hepatol Int, 2018, 12(Suppl 1): 122-134.
|
| [40] |
Caraceni P, Domenicali M, Tovoli A, et al. Clinical indications for the albumin use: still a controversial issue[J]. Eur J Intern Med, 2013, 24(8): 721-728.
|
| [41] |
Sümpelmann R, Becke K, Brenner S, et al. Perioperative intravenous fluid therapy in children: guidelines from the Association of the Scientific Medical Societies in Germany[J]. Paediatr Anaesth, 2017, 27(1): 10-18.
|
| [42] |
张宸溪, 曹竹君, 谢青. 白蛋白在失代偿期肝硬化治疗中的新认识[J]. 肝脏, 2021, 26(5): 479-483.
|
| [43] |
Rasmussen KC, Johansson PI, Højskov M, et al. Hydroxyethyl starch reduces coagulation competence and increases blood loss during major surgery: results from a randomized controlled trial[J]. Ann Surg, 2014, 259(2): 249-254.
|
| [44] |
Ahn HJ, Kim JA, Lee AR, et al. The risk of acute kidney injury from fluid restriction and hydroxyethyl starch in thoracic surgery[J]. Anesth Analg, 2016, 122(1): 186-193.
|
| [45] |
Jacob M, Chappell D, Conzen P, et al. Small-volume resuscitation with hyperoncotic albumin: A systematic review of randomized clinical trials[J]. Crit Care, 2008, 12(2): R34.
|
| [46] |
Löffel LM, Hahn RG, Engel D, et al. Intraoperative intravascular effect of lactated ringer’s solution and hyperoncotic albumin during hemorrhage in cystectomy patients[J]. Anesth Analg, 2021, 133(2): 413-422.
|
| [47] |
Namekata K, Takamori S, Kojima K, et al. Significant changes in the serum levels of IL-6, h-HGF, and type Ⅳ collagen 7S during the perioperative period of a hepatectomy: relevance to SIRS[J]. Surg Today, 2000, 30(5): 403-409.
|
| [48] |
曹晖, 陈亚进, 顾小萍, 等. 中国加速康复外科临床实践指南（2021版）[J]. 中国实用外科杂志, 2021, 41(9): 961-992.
|
| [49] |
University Hospital Consortium. Guidelines for use of albumin[EB/OL]. (2010-04) [2022-08-09].
URL
|
| [50] |
中华医学会外科学分会外科手术学学组, 中国医疗保健国际交流促进会, 加速康复外科学分会肝脏外科学组. 肝切除术后加速康复中国专家共识（2017版）[J]. 临床肝胆病杂志, 2017, 33(10): 1876-1882.
|
| [51] |
曹青青, 周瑾, 李悦悦, 等. 高、低浓度人血白蛋白在原发性肝癌患者半肝切除术后的应用比较[J]. 实用临床医药杂志, 2018, 22(21): 46-48.
|
| [52] |
Lundsgaard-Hansen P, Collins JA, David-West AS, et al. Use of plasma volume substitutes and plasma in developing countries[J]. Bull World Health Organ, 1983, 61(1): 7-22.
|
| [53] |
Groeneveld AB. Albumin and artificial colloids in fluid management: where does the clinical evidence of their utility stand?[J]. Crit Care, 2000, 4 Suppl 2: S16-S20.
|
| [54] |
Ingraham NE, Tignanelli CJ, Menk J, et al. Pre- and peri-operative factors associated with chronic critical illness in liver transplant recipients[J]. Surg Infect (Larchmt), 2020, 21(3): 246-254.
|
| [55] |
刘媛媛, 张雅鑫, 冀召帅, 等. 基于国内外指南分析某院外科住院患者人血清白蛋白临床使用情况[J]. 中国药业, 2022, 31(3): 124-127.
|
| [56] |
Sahmeddini MA, Janatmakan F, Khosravi MB, et al. Restricted crystalloid fluid therapy during orthotopic liver transplant surgery and its effect on respiratory and renal insufficiency in the early post-operative period: A randomized clinical trial[J]. Int J Organ Transplant Med, 2014, 5(3): 113-119.
|
| [57] |
薛欣, 袁莉, 李如霞, 等. 人血白蛋白和羟乙基淀粉对肝移植术后早期肺部并发症的影响[J/CD]. 中华移植杂志（电子版）, 2016, 10(4): 169-173.
|
| [58] |
Park HJ, Seo KI, Kim SJ, et al. Effectiveness of albumin-bilirubin score as a predictor of post-hepatectomy liver failure in patients with hepatocellular carcinoma[J]. Korean J Gastroenterol, 2021, 77(3): 115-122.
|
| [59] |
Benefit L, Benefit M. Guidelines for intravenous albumin administration at Stanford health care[J/OL]. MMWR Recommend Reports, 2003, 52(RR10): 1-42.
|
| [60] |
Ertmer C, Kampmeier TG, Volkert T, et al. Impact of human albumin infusion on organ function in orthotopic liver transplantation--a retrospective matched-pair analysis[J]. Clin Transplant, 2015, 29(1): 67-75.
|
| [61] |
Abbas M, Pires D, Peters A, et al. Conflicts of interest in infection prevention and control research: no smoke without fire. A narrative review[J]. Intensive Care Med, 2018, 44(10): 1679-1690.
|